ACVC Premium Access

Efficacy and safety of pharmacoinvasive strategy compared with primary PCI in patients with STEMI presenting to non-PCI hubs: A real world study

Congress Presentation

About the speaker

Doctor Andrea Gallardo-Grajeda

University Hospital of Santiago de Compostela, Santiago de Compostela (Spain)
0 follower

6 more presentations in this session

First medical contact place determines prognosis in a regional STEMI network. Is time the most important factor?

Speaker: Doctor O. De Diego Soler (Barcelona, ES)

Thumbnail

Prevalence and main causes of myocardial infarction type 2 in the structure of in-hospital mortality

Speaker: Associate Professor I. Leonova (Saint Petersburg, RU)

Thumbnail

Time to percutaneous coronary intervention in patients with ST-elevation myocardial infarction undergoing successful systemic fibrinolysis: does early or late make a difference?

Speaker: Doctor C. Jackson-Pedroza (Mexico City, MX)

Thumbnail

An analysis based on sex&gender in the chest pain unit of an emergency department during the last 12 years.

Speaker: Ms G. Martinez-Nadal (Barcelona, ES)

Thumbnail

Women and elderly: do we delay treatment even after identifying ST-segment elevation?

Speaker: Doctor P. Araujo Leite Medeiros (Braga, PT)

Thumbnail

Access the full session

Live Abstract session - Acute Coronary Syndromes 2 - Focus on systems of care

Speakers: Doctor A. Gallardo-Grajeda, Doctor O. De Diego Soler, Associate Professor I. Leonova, Doctor C. Jackson-Pedroza, Ms G. Martinez-Nadal...
Thumbnail

About the event

Image

ACVC 2021

13 March - 14 March 2021

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb